I'm from the country of Ozempic and Wegovy and neither Novo Nordisk nor our media have been portraying these drugs as general purpose anti-addiction drugs. However there have been some international studies that reveal that it might actually be. Can Novo Nordisk extend their patent of their existing drug if they find new applications for the drug?

Some of Silicon Valley's excess productivity over the rest of the world is driven by ADHD medication. Curious what happens when they also start taking GLP-1 medication.